This section is devoted to the Contract Manufacturing of Pharmaceuticals at the facilities of independent producers, who are fully compliant with technological processes and Quality Control in accordance with client requirements
Pharmaceutical Contract Manufacturing. Technology Transfer
Types of Contractors
- Manufacturers, who specialize only in Contract Manufacturing
- Manufacturers, who produce their own brands along with Contract Manufacturing
Types of Contract Services
- Full-cycle manufacturing
- Performing only some of the manufacturing operations (ex. packaging)
Avara Pharmaceutical Services, a world-class contract development and manufacturing organization acquires the largest sterile manufacturing facility for injectable medicines in Canada from a leading global pharmaceutical company.
Bayer intends to raise the share of its localized products in Russia to 30% of the total sales. The company is already implementing a number of large-scale projects to localize the manufacturing of innovative medicines
Russian Prime Minister Dmitry Medvedev signed the Decree No. 572 of May 12, 2018, aimed at supporting the manufacturers of medicinal products that perform all stages of production.
It will be possible to register drugs that have the same international nonproprietary names, but different trade names, and being manufactured at the same site. The corresponding government bill was adopted by the State Duma.
The representatives of pharmaceutical companies met at the forum of the Adam Smith Institute where they shared their views on the development of local and contract manufacturing.
According to report from The Business Research Company, the global market for clinical trial services to biopharmaceutical and medical device companies is forecast to grow at 12 per cent year on year to 2021.
Grand River Aseptic Manufacturing (GRAM), a leading parenteral contract development and manufacturing organization has announced its second major equipment purchase this year.
According to the Governor of Kaluga region Anatoly Artamonov, Kaluga pharmaceutical cluster achieved significant results over the seven years of its existence.
Mayne Pharma Group, a branded and generic pharmaceuticals company, opened new $80-million, oral solid-dose commercial manufacturing facility in Greenville, North Carolina, USA.